Genenta Science S.p.A., a company active in the development of gene therapies for the fight against cancer, is the first Italian biotech company to be listed on the US hi-tech Nasdaq Capital Market.
The team of Giovannelli e Associati was led by partners Andrea Bartolucci and Gianvittorio Giroletti Angeli assisted by associates Marco Tapparo, Annalisa Zorzut and Camilla Lanzafame for the Italian capital market and corporate aspects, by partner Riccardo Pontremoli for administrative/regulatory law aspects and by of counsel Giuseppe Matarazzo for labour law profiles.
Read More: